Хімічний шафа для зберігання

Основна інформація

• Доступно на:
• English
• Український

Product Description:

The EarlyTect Colon Cancer Test is a groundbreaking medical solution designed to detect colorectal cancer in its early stages. This product has received approval from the Korea Ministry of Food and Drug Safety after successful clinical trials conducted at prestigious medical centers such as Yonsei Medical Center, Severance Hospital, and Severance Check-up Center.

During these clinical trials, 585 men and women aged 30 to 80 were selected as eligible subjects. The test, which utilizes fecal DNA, demonstrated an impressive 90% sensitivity and specificity in diagnosing colorectal cancer. By measuring methylated Syndecan-2, a biomarker closely linked to the development of precancerous lesions in colorectal tissue, EarlyTect accurately identifies the presence of colorectal cancer.

Please note that this product is not intended to provide a definitive confirmation of colorectal cancer. If a subject tests positive, there is a possibility of either colorectal cancer or the presence of precancerous lesions related to colorectal cancer.

Product Standard:

- Cancer Type: Colorectal Cancer
- Subject: Asymptomatic individuals for colorectal cancer screening
- Biomarker: SDC2 mRNA

The price of the EarlyTect Colon Cancer Test and its transaction conditions can be negotiated. To proceed with a purchase, kindly request a quote for the transaction.